Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
remdesivir
Manufacturing
Gilead recalls one lot of COVID drug over particulate concerns
Gilead Sciences has issued a voluntary recall of one lot of COVID-19 antiviral Veklury after confirming "the presence of a glass particle" in a vial.
Joseph Keenan
Sep 25, 2024 8:57am
Lilly to provide insulin API at a reduced cost for Africa
Dec 14, 2022 10:20am
Gilead reports $5.6B in '21 Veklury sales, projects $2B in '22
Feb 2, 2022 7:05am
Gilead starts oral remdesivir trial as Veklury goes outpatient
Jan 24, 2022 8:55am
With report, Gilead's slumping COVID-19 drug takes another hit
Sep 17, 2021 11:44am
Cipla reopens plant in South Africa a month after it was looted
Aug 23, 2021 9:46am
